**Core Concept**
The question is testing the relationship between chronic myeloid leukemia (CML) and vitamin B12 metabolism. In CML, a neoplastic clone of granulocytes accumulates, leading to an abnormal increase in granulocytes. This neoplastic process affects various biochemical pathways, including vitamin B12 metabolism.

**Why the Correct Answer is Right**
In CML, the serum vitamin B12 level is elevated due to the increased activity of the enzyme transcobalamin I, which binds to vitamin B12 in the plasma. The elevated levels of granulocytes in CML result in an increased production of transcobalamin I, leading to an increase in serum vitamin B12 levels. This is a characteristic feature of CML, which can be used as a diagnostic marker.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not accurately describe the relationship between CML and vitamin B12 levels. There is no evidence to suggest that vitamin B12 levels are decreased in CML.
* **Option B:** This option is incorrect because it is not specific to CML. Elevated vitamin B12 levels can be seen in other conditions, such as liver disease or pancreatic insufficiency.
* **Option C:** This option is incorrect because it is not a characteristic feature of CML. Vitamin B12 levels are not typically elevated in acute myeloid leukemia (AML).

**Clinical Pearl / High-Yield Fact**
In CML, the increased levels of vitamin B12 can lead to a false diagnosis of pernicious anemia if not considered in the differential diagnosis.

**Correct Answer: C. Elevated.